table of content
Table of Contents
Post-pandemic Era-Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Polymerase Chain Reaction (PCR) -Product Introduction and Major Company
1.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) -Product Introduction and Major Company
1.1.3 Microarrays -Product Introduction and Major Company
1.1.4 Next-Generation Sequencing (NGS) -Product Introduction and Major Company
1.1.5 Hybridization -Product Introduction and Major Company
1.1.6 Others -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Molecular Diagnostics in Infectious Disease Testing Market Assessment by Type
3.1 Global Molecular Diagnostics in Infectious Disease Testing Sales by Type (2018-2028)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Type (2018-2028)
3.3 North America Molecular Diagnostics in Infectious Disease Testing Sales and Revenue by Type (2018-2028)
3.4 Asia Molecular Diagnostics in Infectious Disease Testing Sales and Revenue by Type (2018-2028)
3.5 Europe Molecular Diagnostics in Infectious Disease Testing Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Sales and Revenue by Type (2018-2028)
3.7 South America Molecular Diagnostics in Infectious Disease Testing Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Molecular Diagnostics in Infectious Disease Testing Market Assessment by Application
4.1 Global Molecular Diagnostics in Infectious Disease Testing Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Molecular Diagnostics in Infectious Disease Testing Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Molecular Diagnostics in Infectious Disease Testing Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Molecular Diagnostics in Infectious Disease Testing Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Molecular Diagnostics in Infectious Disease Testing Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
6.3 India Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
7.3 France Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Molecular Diagnostics in Infectious Disease Testing Sales, Revenue and Growth Rate (2018-2028)
10 Global Molecular Diagnostics in Infectious Disease Testing Average Price Trend
10.1 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in North America (2018-2028)
10.2 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Asia (2018-2028)
10.3 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Europe (2018-2028)
10.4 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Molecular Diagnostics in Infectious Disease Testing in South America (2018-2028)
11 Value Chain
11.1 Molecular Diagnostics in Infectious Disease Testing Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Molecular Diagnostics in Infectious Disease Testing Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Molecular Diagnostics in Infectious Disease Testing Market, Competitive Analysis
12.1 Abbott
12.1.1 Abbott Company Profiles and Company News
12.1.2 Abbott Product Introduction
12.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 BD
12.2.1 BD Company Profiles and Company News
12.2.2 BD Product Introduction
12.2.3 BD Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 BioMerieux
12.3.1 BioMerieux Company Profiles and Company News
12.3.2 BioMerieux Product Introduction
12.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Profiles and Company News
12.4.2 Thermo Fisher Scientific Product Introduction
12.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 GenMark Diagnostics
12.5.1 Roche Company Profiles and Company News
12.5.2 Roche Product Introduction
12.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Siemens
12.6.1 Siemens Company Profiles and Company News
12.6.2 Siemens Product Introduction
12.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Veridex
12.7.1 Veridex Company Profiles and Company News
12.7.2 Veridex Product Introduction
12.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Luminex
12.8.1 Luminex Company Profiles and Company News
12.8.2 Luminex Product Introduction
12.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 GenMark Diagnostics
12.9.1 GenMark Diagnostics Company Profiles and Company News
12.9.2 GenMark Diagnostics Product Introduction
12.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Qiagen
12.10.1 Qiagen Company Profiles and Company News
12.10.2 Qiagen Product Introduction
12.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
12.11 Genomix Biotech
12.12 BioTheranostics
13 Global Molecular Diagnostics in Infectious Disease Testing Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Molecular Diagnostics in Infectious Disease Testing Market
13.2 Concentration Ratio (CR5) of Global Molecular Diagnostics in Infectious Disease Testing Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Molecular Diagnostics in Infectious Disease Testing Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
